Phase 3 Polio Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 3
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121
Completed
Phase 3Phase 4
Comparison of Immunogenicity and Safety of Sabin and Salk Inactivated Poliovirus Vaccine in Infant Immunization
Poliomyelitis
World Health Organization460 enrolled1 locationACTRN12622000929707